BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 16621000)

  • 1. Pseudomonas aeruginosa bacteraemia in cancer patients.
    Krcmery V; Koprnova J; Gogova M; Grey E; Korcova J
    J Infect; 2006 Jun; 52(6):461-3. PubMed ID: 16621000
    [No Abstract]   [Full Text] [Related]  

  • 2. Favourable outcomes in episodes of Pseudomonas bacteraemia when associated with tunnelled cuffed catheters (TCCs) in chronic haemodialysis patients.
    Golestaneh L; Laut J; Rosenberg S; Zhang M; Mokrzycki MH
    Nephrol Dial Transplant; 2006 May; 21(5):1328-33. PubMed ID: 16421157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pseudomonas aeruginosa bacteraemia in burns patients: Risk factors and outcomes.
    Mahar P; Padiglione AA; Cleland H; Paul E; Hinrichs M; Wasiak J
    Burns; 2010 Dec; 36(8):1228-33. PubMed ID: 20965109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudomonas aeruginosa bacteremia in children.
    Koprnova J; Korcova J; Gogova M; Krcmery V
    Eur J Epidemiol; 2004; 19(5):499-500. PubMed ID: 15233326
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical features and outcome of patients with community-acquired Pseudomonas aeruginosa bacteraemia.
    Kang CI; Kim SH; Park WB; Lee KD; Kim HB; Kim EC; Oh MD; Choe KW
    Clin Microbiol Infect; 2005 May; 11(5):415-8. PubMed ID: 15819873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imipenen-resistant Ps. aeruginosa bacteraemia in cancer patients: risk factors, clinical features and outcome.
    Krcmery V; Trup J; Kunova A; Spanik S; Drgona L; Oravcova E; Studena M; Lacka J; Sevcikova L; Koren P; Kukuckova E; Stopkova K; Krupova I; Grausova S; Svec J
    Int J Clin Pharmacol Res; 1996; 16(2-3):43-9. PubMed ID: 9063755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pattern of gram negative rods bacteraemia in diabetic patients in Ibadan, Nigeria.
    Oni AA; Ogunkunle MO; Oke AA; Bakare RA
    Afr J Med Med Sci; 2000; 29(3-4):207-10. PubMed ID: 11713990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of 30-day mortality among patients with Pseudomonas aeruginosa bloodstream infections: impact of delayed appropriate antibiotic selection.
    Lodise TP; Patel N; Kwa A; Graves J; Furuno JP; Graffunder E; Lomaestro B; McGregor JC
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3510-5. PubMed ID: 17646415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Editorial commentary: combination therapy for Pseudomonas aeruginosa bacteremia: where do we stand?
    Paul M; Leibovici L
    Clin Infect Dis; 2013 Jul; 57(2):217-20. PubMed ID: 23580731
    [No Abstract]   [Full Text] [Related]  

  • 10. Pseudomonas aeruginosa bloodstream infections: how should we treat them?
    van Delden C
    Int J Antimicrob Agents; 2007 Nov; 30 Suppl 1():S71-5. PubMed ID: 17698326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics and risk factors for mortality in patients with bacteremia caused by Pseudomonas aeruginosa.
    Horino T; Chiba A; Kawano S; Kato T; Sato F; Maruyama Y; Nakazawa Y; Yoshikawa K; Yoshida M; Hori S
    Intern Med; 2012; 51(1):59-64. PubMed ID: 22214624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imipenem-resistant Ps. aeruginosa bacteraemia in cancer patients: risk factors, clinical features and outcome.
    Krcméry V; Trupl J; Kunová A; Spánik S; Ilavská I; Hel'pianska L; Bezáková I; Drgona L; Oravcová E; Studená M; Lacka J; Sevcíková L; Koren P; Kukucková E; Stopková K; Krupová I; Grausová S; Svec J
    Bratisl Lek Listy; 1996 Nov; 97(11):647-51. PubMed ID: 9117427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacteraemia due to Pseudomonas putida and other Pseudomonas non-aeruginosa in children.
    Korcova J; Koprnova J; Krcmery V; Krcmery V
    J Infect; 2005 Jul; 51(1):81. PubMed ID: 15979496
    [No Abstract]   [Full Text] [Related]  

  • 14. Catheter salvage in a patient on hemodialysis with a catheter-related bacteremia by Pseudomonas aeruginosa. Usefulness of clarithromycin.
    Gascón A; Iglesias E; Zabala S; Bélvis JJ
    Am J Nephrol; 2000; 20(6):496-7. PubMed ID: 11146320
    [No Abstract]   [Full Text] [Related]  

  • 15. Ecthyma gangrenosum: sign of Pseudomonas aeruginosa bacteremia.
    Demircioğlu F; Oren H
    Pediatr Hematol Oncol; 2008 Jun; 25(4):369-70. PubMed ID: 18484484
    [No Abstract]   [Full Text] [Related]  

  • 16. Stenotrophomonas maltophilia bacteraemia in cancer patients: report on 31 cases.
    Krcmery V; Pichna P; Oravcova E; Lacka J; Kukuckova E; Studena M; Grausova S; Stopkova K; Krupova I
    J Hosp Infect; 1996 Sep; 34(1):75-7. PubMed ID: 8880554
    [No Abstract]   [Full Text] [Related]  

  • 17. An 18-case outbreak of drug-resistant Pseudomonas aeruginosa bacteriemia in hematology patients.
    Micol JB; de Botton S; Guieze R; Coiteux V; Darre S; Dessein R; Leroy O; Yakoub-Agha I; Quesnel B; Bauters F; Beaucaire G; Alfandari S
    Haematologica; 2006 Aug; 91(8):1134-8. PubMed ID: 16885056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of empiric aminoglycoside monotherapy for Pseudomonas aeruginosa bacteremia.
    Phe K; Bowers DR; Babic JT; Tam VH
    Diagn Microbiol Infect Dis; 2019 Apr; 93(4):346-348. PubMed ID: 30522794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of AmpC overexpression on outcomes of patients with Pseudomonas aeruginosa bacteremia.
    Tam VH; Chang KT; Schilling AN; LaRocco MT; Genty LO; Garey KW
    Diagn Microbiol Infect Dis; 2009 Mar; 63(3):279-85. PubMed ID: 19135330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
    Deal EN; Micek ST; Reichley RM; Ritchie DJ
    Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.